Personalized medicine, genetic testing could shape the future of non-small cell lung cancer
from Cure Today
While identifying new genetic targets and developing novel drugs is important for the future of non-small cell lung cancer, more emphasis should be put on improving patient access to existing targeted treatments, according to Dr. Nathan A. Pennell.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063